Camilla Canepa, the eighteen year old from Sestri Levante who died after being vaccinated with the first dose of AstraZeneca, would have been suffering from an autoimmune disease, not indicated in the anamnestic form completed before the injection. According to the investigations of the Public Prosecutor of Genoa, determined to ascertain any responsibility, the girl would have suffered from thrombocytopenia, a condition that could have been judged incompatible with the administration of Anglo-Swedish serum. The disease, however, would not appear in the information that Camilla provided to the vaccinating doctors, and the investigations of the Prosecutor’s Office, to date, would be aimed at establishing whether the girl was aware of her condition.
A condition to which, in the last few weeks, a hormonal cure for the treatment of a cyst would have been added.
According to what was collected by the Corriere della Sera, Camilla would have been prescribed a therapy based on Progynova (hormones) e Dufaston (estrogen), drugs that carry a thrombotic risk. Investigations should, therefore, also ascertain the responsibilities of the doctor, who is said to have prescribed the therapy on May 29, four days after receiving the first dose of AstraZeneca. Camilla Canepa was hospitalized for the first time on June 3, while on June 5 she underwent an emergency operation, after which however she suffered from cerebral hemorrhage.
READ ALSO
Thrombosis at 18, Camilla did not make it. Change the vaccination campaign